Search
This on-demand webinar will cover method development considerations for applied workflows such as toxicology research, implementing fast chromatography, and automated intelligent instrument control. Participants will learn how to leverage higher energy dissociation (HCD) and resonant collisional dissociation (CID) using tMS2 and tMS3 acquisition to improve quantitative selectivity, sensitivity, and specificity in complex biological matrices.
You will learn:
- How to increase productivity through streamlined method creation
- How to create targeted MS2 and MS3 methods in one analytical method
- The benefits of Adaptive RT for scheduled PRM acquisition for small molecules
About the presenters
Jingshu Guo, Ph.D, Sr. Product Application Specialist in the Clinical Vertical Marketing Group, Thermo Fisher Scientific
Dr. Jingshu Guo is a trained mass spectrometrist with 10+ years of experience in LC-MS-based qualitative and quantitative analyses of small molecules, nucleosides, peptides, and intact protein. After joining Thermo Fisher Scientific, she worked on the method development, implementation, and optimization in healthcare, clinical and toxicology-related fields. One of her current focuses is to develop fast quantification methods in small molecules, such as biomarkers, therapeutic drugs, and drugs of abuse in biofluids using LC coupled to triple quadrupole MS, ion trap MS, or high-resolution MS, and LC-free MS platforms.
Courtney Patterson, Masters of Science, Product Specialist in the Clinical Vertical Marketing Group, Thermo Fisher Scientific
Courtney Patterson is an Application Scientist in Clinical and Forensic Toxicology at Thermo Fisher Scientific based out of San Jose, CA. She has a background in forensic toxicology, receiving her master’s in forensic chemistry from The Pennsylvania State University. Her previous role was working as a Forensic Toxicologist for the US Army in their Forensic Toxicology Drug Testing Laboratory (FTDTL) in Fort Meade, MD. Recently, she has been developing fast, quantitative LCMS workflows for drugs of abuse and novel psychoactive substances (NPS) to be utilized by forensic labs in a production setting.